Forbes December 4, 2024
Alex Knapp

Plus: UnitedHealthcare CEO was fatally shot

This week, the FDA issued recommendations for streamlining the clearance process for AI-powered medical devices. The memo announcing this change recognizes that the utilization of AI in devices “is an iterative process” and aims to make it easier to improve software within the regulatory process.

The guidance, which is not legally enforceable but “describe the Agency’s current thinking” suggests that manufacturers could provide a plan for updating AI-powered software in medical devices that would reduce the need to file for a new clearance from the regulatory body. Instead, manufacturers would submit proposed changes to software, a proposal for testing those changes for safety and efficacy and strategies to minimize the risk of updates.

UnitedHealthcare...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Medical Devices, Technology
Related Articles:
Opinion: STAT+: How will the Center for Biologics Evaluation and Research change under RFK Jr.?
How the FDA Opens the Door to Risky Chemicals in America’s Food Supply
FDA OKs First Gene Therapy Implant for a Rare Eye Disease
Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder
FDA nominee pitches AI application review

Share This Article